L'Oréal Joins $5M Funding for Indian Skincare Startup CHOSEN to Target Melanin-Rich Skin

Chennai-based dermo-cosmetic brand CHOSEN has secured $5 million in a Series A funding round.
Fireside Ventures led the investment, with participation from L'Oréal's corporate venture capital arm BOLD, Alkemi Growth Capital, and angel investor Avnish Anand.
Boosting Science-Led Innovation
The fresh capital will fuel CHOSEN's research and development efforts in exposome-based skincare tailored for Indian consumers.
Exposome science examines how environmental factors like pollution impact skin, a key concern in urban India.
Rising Star in D2C Beauty
Founded by dermatologists, CHOSEN previously raised $1.2 million in seed funding from friends and family.
The startup focuses on products for melanin-rich skin tones, addressing a gap left by global brands optimized for lighter skin.
This funding underscores L'Oréal's growing bet on India's booming direct-to-consumer skincare market, now valued at billions.
India's D2C beauty sector has exploded post-pandemic, with consumers seeking personalized, affordable science-backed solutions.
By partnering with CHOSEN, L'Oréal gains insights into local preferences, potentially paving the way for acquisitions or co-branded lines.
For everyday Indians battling pollution and humidity, CHOSEN's approach promises effective, dermatologist-approved care without breaking the bank.
Looking ahead, this infusion positions CHOSEN for national expansion and possible international foray into other skin-of-color markets.
The deal highlights how global giants are scouting Indian startups to stay ahead in the personalized beauty revolution.









